{"id":58023,"date":"2025-10-15T10:57:09","date_gmt":"2025-10-15T10:57:09","guid":{"rendered":"https:\/\/ibima.eu\/?page_id=58023"},"modified":"2026-09-29T08:36:11","modified_gmt":"2026-09-29T08:36:11","slug":"era4health-iics4all-2027","status":"publish","type":"page","link":"https:\/\/ibima.eu\/es\/era4health-iics4all-2027\/","title":{"rendered":"era4health-iics4all-2027"},"content":{"rendered":"<p>[et_pb_section fb_built=\u00bb1&#8243; admin_label=\u00bbsection\u00bb _builder_version=\u00bb4.25.1&#8243; custom_padding=\u00bb||0px|||\u00bb locked=\u00bboff\u00bb collapsed=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_row column_structure=\u00bb1_5,3_5,1_5&#8243; _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb21px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb1_5&#8243; _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_column][et_pb_column type=\u00bb3_5&#8243; _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_image src=\u00bbhttps:\/\/ibima.eu\/wp-content\/uploads\/2025\/10\/ERA4Health-logo.png\u00bb title_text=\u00bbERA4Health logo\u00bb align=\u00bbcenter\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb width=\u00bb54%\u00bb module_alignment=\u00bbcenter\u00bb custom_margin=\u00bb26px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_image][\/et_pb_column][et_pb_column type=\u00bb1_5&#8243; _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb59px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_heading title=\u00bbERA4Health \u2013 Multi-national Investigator-Initiated Clinical Studies (IICS4all 2027)\u00bb _builder_version=\u00bb4.27.7&#8243; _module_preset=\u00bbdefault\u00bb title_text_align=\u00bbcenter\u00bb title_text_color=\u00bb#0C71C3&#8243; title_line_height=\u00bb1.3em\u00bb module_alignment=\u00bbcenter\u00bb hover_enabled=\u00bb0&#8243; global_colors_info=\u00bb{}\u00bb sticky_enabled=\u00bb0&#8243;][\/et_pb_heading][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb width=\u00bb75.9%\u00bb custom_margin=\u00bb20px|auto||159px|false|false\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text admin_label=\u00bbText\u00bb _builder_version=\u00bb4.27.7&#8243; header_text_color=\u00bb#000000&#8243; background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb width=\u00bb100%\u00bb custom_margin=\u00bb1px|-78px|||false|false\u00bb hover_enabled=\u00bb0&#8243; global_colors_info=\u00bb{}\u00bb sticky_enabled=\u00bb0&#8243;]<\/p>\n<p data-start=\"301\" data-end=\"652\" style=\"text-align: justify;\">La Asociaci\u00f3n Europea ERA4Health ha preanunciado la convocatoria <strong>IICS4all 2027 \u2013 Multi-national Investigator-Initiated Clinical Studies in Cardiovascular, Autoimmune, Metabolic, and Non-Communicable Respiratory Diseases, including Underrepresented Populations<\/strong><em data-start=\"629\" data-end=\"649\">,<\/em> dedicada a financiar ensayos cl\u00ednicos multic\u00e9ntricos e iniciados por investigadores en enfermedades cardiovasculares, trastornos metab\u00f3licos, enfermedades autoinmunes y enfermedades respiratorias no transmisibles.<\/p>\n<p>[\/et_pb_text][et_pb_heading title=\u00bbObjetivos de la convocatoria\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb title_font=\u00bb|||on|||||\u00bb title_text_color=\u00bb#0C71C3&#8243; min_height=\u00bb0px\u00bb custom_margin=\u00bb20px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover_enabled=\u00bbon|desktop\u00bb][\/et_pb_heading][\/et_pb_column][\/et_pb_row][et_pb_row admin_label=\u00bbrow\u00bb _builder_version=\u00bb4.25.1&#8243; background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb width=\u00bb77.1%\u00bb custom_margin=\u00bb|-259px||161px||\u00bb custom_padding=\u00bb|0px||9px||\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_text admin_label=\u00bbText\u00bb _builder_version=\u00bb4.27.7&#8243; header_text_color=\u00bb#000000&#8243; background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb width=\u00bb100%\u00bb custom_margin=\u00bb11px|-78px|||false|false\u00bb hover_enabled=\u00bb0&#8243; global_colors_info=\u00bb{}\u00bb sticky_enabled=\u00bb0&#8243;]<\/p>\n<p data-pm-slice=\"1 1 []\"><span>El objetivo de <\/span><strong><span>IICS4all 2027<\/span><\/strong><span> es apoyar <\/span><strong><span>estudios cl\u00ednicos pragm\u00e1ticos, multinacionales, intervencionistas, aleatorizados y controlados de fase III<\/span><\/strong><span>, iniciados por investigadores y de elevada relevancia para la salud p\u00fablica.<\/span><\/p>\n<p><span>Los estudios deber\u00e1n responder a uno o ambos de los siguientes enfoques:<\/span><\/p>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul data-spread=\"false\">\n<li>\n<p>Estudios de <strong>efectividad comparativa<\/strong> (comparative-effectiveness studies).<\/p>\n<\/li>\n<li>\n<p>Estudios de <strong>reposicionamiento de medicamentos<\/strong> utilizando medicamentos fuera de patente.<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p data-pm-slice=\"1 1 []\"><span>Las propuestas deber\u00e1n abordar principalmente, al menos, una de las siguientes \u00e1reas, todas ellas consideradas de igual importancia:<\/span><\/p>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul data-spread=\"false\">\n<li>\n<p><strong><span>Enfermedades cardiovasculares.<\/span><\/strong><\/p>\n<\/li>\n<li>\n<p><strong><span>Trastornos metab\u00f3licos.<\/span><\/strong><\/p>\n<\/li>\n<li>\n<p><strong><span>Enfermedades autoinmunes.<\/span><\/strong><\/p>\n<\/li>\n<li>\n<p><strong><span>Enfermedades respiratorias no transmisibles.<\/span><\/strong><\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p><span>Los estudios podr\u00e1n abordar una \u00fanica enfermedad o condici\u00f3n, varias de las \u00e1reas anteriores y\/o combinarlas con <\/span><strong><span>comorbilidades relacionadas<\/span><\/strong><span>.<\/span><\/p>\n<ul data-spread=\"false\" style=\"text-align: justify;\"><\/ul>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb width=\u00bb75.9%\u00bb custom_margin=\u00bb4px|auto||159px|false|false\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_heading title=\u00bb\u00c1reas prioritarias de inter\u00e9s\u00bb _builder_version=\u00bb4.27.7&#8243; _module_preset=\u00bbdefault\u00bb title_font=\u00bb|||on|||||\u00bb title_text_color=\u00bb#0C71C3&#8243; min_height=\u00bb0px\u00bb custom_margin=\u00bb12px||||false|false\u00bb hover_enabled=\u00bb0&#8243; global_colors_info=\u00bb{}\u00bb custom_padding__hover_enabled=\u00bbon|desktop\u00bb sticky_enabled=\u00bb0&#8243;][\/et_pb_heading][et_pb_text _builder_version=\u00bb4.27.7&#8243; _module_preset=\u00bbdefault\u00bb custom_padding=\u00bb||0px|11px||\u00bb hover_enabled=\u00bb0&#8243; global_colors_info=\u00bb{}\u00bb custom_margin=\u00bb11px||||false|false\u00bb sticky_enabled=\u00bb0&#8243;]<\/p>\n<p data-start=\"1464\" data-end=\"1579\">Las propuestas deber\u00e1n centrarse en al menos una de las siguientes \u00e1reas, todas consideradas de igual relevancia:<\/p>\n<ul data-start=\"1580\" data-end=\"1735\">\n<li data-start=\"1580\" data-end=\"1617\">\n<p data-start=\"1582\" data-end=\"1617\"><strong data-start=\"1582\" data-end=\"1615\">Enfermedades cardiovasculares<\/strong><\/p>\n<\/li>\n<li data-start=\"1618\" data-end=\"1648\">\n<p data-start=\"1620\" data-end=\"1648\"><strong data-start=\"1620\" data-end=\"1646\">Trastornos metab\u00f3licos<\/strong><\/p>\n<\/li>\n<li data-start=\"1649\" data-end=\"1735\">\n<p data-start=\"1651\" data-end=\"1735\"><strong data-start=\"1651\" data-end=\"1679\">Enfermedades autoinmunes<\/strong> (incluidas enfermedades inflamatorias inmunomediadas)<\/p>\n<\/li>\n<\/ul>\n<p data-start=\"1737\" data-end=\"1822\">Podr\u00e1n abordarse una sola enfermedad o combinaciones con comorbilidades relevantes.<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.7&#8243; _module_preset=\u00bbdefault\u00bb width=\u00bb75.9%\u00bb min_height=\u00bb280.9px\u00bb custom_margin=\u00bb9px|auto||159px|false|false\u00bb hover_enabled=\u00bb0&#8243; global_colors_info=\u00bb{}\u00bb sticky_enabled=\u00bb0&#8243;][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_heading title=\u00bbTipos de intervenciones que se incuyen\u00bb _builder_version=\u00bb4.27.7&#8243; _module_preset=\u00bbdefault\u00bb title_font=\u00bb|||on|||||\u00bb title_text_color=\u00bb#0C71C3&#8243; min_height=\u00bb0px\u00bb custom_margin=\u00bb21px||||false|false\u00bb hover_enabled=\u00bb0&#8243; global_colors_info=\u00bb{}\u00bb custom_padding__hover_enabled=\u00bbon|desktop\u00bb sticky_enabled=\u00bb0&#8243;][\/et_pb_heading][et_pb_text _builder_version=\u00bb4.27.7&#8243; _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb||-28px|||\u00bb custom_padding=\u00bb|||11px||\u00bb hover_enabled=\u00bb0&#8243; global_colors_info=\u00bb{}\u00bb sticky_enabled=\u00bb0&#8243;]<\/p>\n<p data-pm-slice=\"1 3 []\" style=\"text-align: justify;\">Las intervenciones podr\u00e1n incluir, entre otras, diagn\u00f3stico, cribado, prevenci\u00f3n y tratamiento; intervenciones farmacol\u00f3gicas, nutricionales y de estilo de vida; cirug\u00eda; m\u00e9todos de pron\u00f3stico; dispositivos m\u00e9dicos; nanotecnolog\u00eda y tecnolog\u00edas sanitarias avanzadas; intervenciones de eHealth y digitales; y otras intervenciones sanitarias existentes.<\/p>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul data-spread=\"true\">\n<li>\n<p style=\"text-align: justify;\">En los estudios de <strong>reposicionamiento de medicamentos<\/strong>, explorar una nueva indicaci\u00f3n de un medicamento aprobado y fuera de patente.\u00a0<\/p>\n<\/li>\n<li style=\"text-align: justify;\">\n<p>Integrar adecuadamente las dimensiones de d<strong>sexo, g\u00e9nero, edad y diversidad.<\/strong><\/p>\n<\/li>\n<li style=\"text-align: justify;\">\n<p>Garantizar que la poblaci\u00f3n estudiada represente adecuadamente a la poblaci\u00f3n a la que est\u00e1 destinada la intervenci\u00f3n.<\/p>\n<\/li>\n<li style=\"text-align: justify;\">\n<p><strong>Incluir adecuadamente poblaciones infrarrepresentadas y vulnerables<\/strong>, considerando, cuando proceda, minor\u00edas y aspectos socioecon\u00f3micos y \u00e9tnicos.<\/p>\n<\/li>\n<li style=\"text-align: justify;\">\n<p><strong>No excluir por defecto a mujeres embarazadas o en periodo de lactancia<\/strong>. Cualquier exclusi\u00f3n deber\u00e1 estar debidamente justificada.<\/p>\n<\/li>\n<li>\n<p style=\"text-align: justify;\">Justificar cient\u00edficamente aquellos casos en los que no resulte viable incluir grupos infrarrepresentados o investigar aspectos espec\u00edficos relacionados con sexo, g\u00e9nero, edad u otras dimensiones de diversidad.<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.7&#8243; _module_preset=\u00bbdefault\u00bb width=\u00bb75.9%\u00bb min_height=\u00bb422.9px\u00bb custom_margin=\u00bb9px|auto||159px|false|false\u00bb hover_enabled=\u00bb0&#8243; global_colors_info=\u00bb{}\u00bb sticky_enabled=\u00bb0&#8243;][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_heading title=\u00bbRequisitos principales de los proyectos\u00bb _builder_version=\u00bb4.27.7&#8243; _module_preset=\u00bbdefault\u00bb title_font=\u00bb|||on|||||\u00bb title_text_color=\u00bb#0C71C3&#8243; min_height=\u00bb0px\u00bb custom_margin=\u00bb8px||||false|false\u00bb hover_enabled=\u00bb0&#8243; global_colors_info=\u00bb{}\u00bb custom_padding__hover_enabled=\u00bbon|desktop\u00bb sticky_enabled=\u00bb0&#8243;][\/et_pb_heading][et_pb_text _builder_version=\u00bb4.27.7&#8243; _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb||-28px|||\u00bb custom_padding=\u00bb|||11px||\u00bb hover_enabled=\u00bb0&#8243; global_colors_info=\u00bb{}\u00bb sticky_enabled=\u00bb0&#8243;]<\/p>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li data-start=\"1900\" data-end=\"2052\">\n<p data-start=\"1902\" data-end=\"2052\">Dise\u00f1arse como <strong data-start=\"1917\" data-end=\"1946\">ensayos cl\u00ednicos fase III<\/strong>, aleatorizados e intervencionales (con posibilidad de aleatorizaci\u00f3n por clusters si est\u00e1 justificado).<\/p>\n<\/li>\n<li data-start=\"2053\" data-end=\"2260\">\n<p data-start=\"2055\" data-end=\"2260\">Evaluar <strong data-start=\"2063\" data-end=\"2115\">intervenciones sanitarias existentes y aprobadas<\/strong>, tanto farmacol\u00f3gicas como no farmacol\u00f3gicas (p. ej., intervenciones nutricionales, de estilo de vida, quir\u00fargicas, tecnol\u00f3gicas o digitales).<\/p>\n<\/li>\n<li data-start=\"2261\" data-end=\"2466\">\n<p data-start=\"2263\" data-end=\"2466\">Incluir desde el inicio la <strong data-start=\"2290\" data-end=\"2378\">participaci\u00f3n activa de pacientes, profesionales sanitarios y otros usuarios finales.<\/strong><\/p>\n<\/li>\n<li data-start=\"2467\" data-end=\"2625\">\n<p data-start=\"2469\" data-end=\"2625\">Cumplir estrictamente los <strong data-start=\"2495\" data-end=\"2525\">requisitos \u00e9ticos europeos<\/strong> (Reglamento UE 2021\/695) e integrar la <strong data-start=\"2565\" data-end=\"2597\">evaluaci\u00f3n \u00e9tica y de g\u00e9nero<\/strong> en el dise\u00f1o del estudio.<\/p>\n<\/li>\n<li data-start=\"2626\" data-end=\"2761\">\n<p data-start=\"2628\" data-end=\"2761\">Aplicar los principios FAIR (Findability, Accessibility, Interoperability, Reuse) en la <strong data-start=\"2716\" data-end=\"2758\">gesti\u00f3n de datos y muestras biol\u00f3gicas<\/strong>.<\/p>\n<\/li>\n<li data-start=\"2762\" data-end=\"2923\">\n<p data-start=\"2764\" data-end=\"2923\">Considerar de forma expl\u00edcita la <strong data-start=\"2797\" data-end=\"2848\">inclusi\u00f3n de poblaciones diversas y vulnerables<\/strong>.<\/p>\n<\/li>\n<li data-start=\"2924\" data-end=\"3044\">\n<p data-start=\"2926\" data-end=\"3044\">Asegurar la <strong data-start=\"2938\" data-end=\"2959\">equidad de g\u00e9nero<\/strong> tanto en la composici\u00f3n del equipo investigador como en la poblaci\u00f3n participante.<\/p>\n<\/li>\n<li data-start=\"3045\" data-end=\"3161\">\n<p data-start=\"3047\" data-end=\"3161\">Demostrar una <strong data-start=\"3061\" data-end=\"3103\">s\u00f3lida experiencia en ensayos cl\u00ednicos<\/strong> por parte del investigador coordinador y del consorcio.<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p data-start=\"3202\" data-end=\"3236\">Se recomienda que los proyectos:<\/p>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul data-start=\"3237\" data-end=\"3716\">\n<li data-start=\"3237\" data-end=\"3389\">\n<p data-start=\"3239\" data-end=\"3389\">Incluyan <strong data-start=\"3248\" data-end=\"3298\">an\u00e1lisis de impacto sanitario y socioecon\u00f3mico<\/strong>, as\u00ed como una proyecci\u00f3n hacia futuras <strong data-start=\"3338\" data-end=\"3386\">evaluaciones de tecnolog\u00edas sanitarias (HTA)<\/strong>.<\/p>\n<\/li>\n<li data-start=\"3390\" data-end=\"3514\">\n<p data-start=\"3392\" data-end=\"3514\">Aprovechen <strong data-start=\"3403\" data-end=\"3439\">redes multinacionales existentes<\/strong>, cohortes o biobancos previos para garantizar la viabilidad del estudio.<\/p>\n<\/li>\n<li data-start=\"3515\" data-end=\"3610\">\n<p data-start=\"3517\" data-end=\"3610\">Incorporen <strong data-start=\"3528\" data-end=\"3563\">t\u00e9cnicas estad\u00edsticas adecuadas<\/strong> que contemplen la variabilidad entre pa\u00edses.<\/p>\n<\/li>\n<li data-start=\"3611\" data-end=\"3716\">\n<p data-start=\"3613\" data-end=\"3716\">Presenten un <strong data-start=\"3626\" data-end=\"3661\">plan de acceso de los pacientes<\/strong> a los f\u00e1rmacos reutilizados en los distintos pa\u00edses.<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb width=\u00bb75.9%\u00bb min_height=\u00bb325.8px\u00bb custom_margin=\u00bb14px|auto||159px|false|false\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_heading title=\u00bb%22Out of scope%22&#8243; _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb title_font=\u00bb|||on|||||\u00bb title_text_color=\u00bb#0C71C3&#8243; min_height=\u00bb0px\u00bb custom_margin=\u00bb1px||||false|false\u00bb hover_enabled=\u00bb0&#8243; global_colors_info=\u00bb{}\u00bb custom_padding__hover_enabled=\u00bbon|desktop\u00bb sticky_enabled=\u00bb0&#8243;][\/et_pb_heading][et_pb_text _builder_version=\u00bb4.27.7&#8243; _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb4px||||false|false\u00bb custom_padding=\u00bb||0px|11px||\u00bb hover_enabled=\u00bb0&#8243; global_colors_info=\u00bb{}\u00bb sticky_enabled=\u00bb0&#8243;]<\/p>\n<ul>\n<li data-start=\"172\" data-end=\"520\">Estudios cl\u00ednicos realizados con fines comerciales.<\/li>\n<li><span>Estudios en \u00e1reas m\u00e9dicas diferentes de las contempladas en la convocatoria.<\/span><\/li>\n<li data-start=\"172\" data-end=\"520\" style=\"text-align: justify;\"><span>En estudios de reposicionamiento, <\/span>medicamentos que contin\u00faen bajo patente en alguno de los pa\u00edses participantes.<\/li>\n<li data-start=\"172\" data-end=\"520\" style=\"text-align: justify;\">Estudios de fase I y fase II.<\/li>\n<li data-start=\"172\" data-end=\"520\" style=\"text-align: justify;\">Estudios observacionales, estudios de cohortes no intervencionales, estudios de implementaci\u00f3n, estudios traslacionales\/de aprobaci\u00f3n cl\u00ednica, creaci\u00f3n de grandes bases de datos, revisiones sistem\u00e1ticas, metaan\u00e1lisis y estudios no aleatorizados.<\/li>\n<li data-start=\"172\" data-end=\"520\" style=\"text-align: justify;\"><strong><span>Estudios cl\u00ednicos centrados en c\u00e1ncer<\/span><\/strong><span>, incluso cuando el c\u00e1ncer se estudie junto con alguna de las enfermedades o condiciones elegibles.<\/span><\/li>\n<li data-start=\"172\" data-end=\"520\" style=\"text-align: justify;\">Desarrollo de una nueva intervenci\u00f3n sanitaria.<\/li>\n<li data-start=\"172\" data-end=\"520\" style=\"text-align: justify;\"><strong><span>Dispositivos m\u00e9dicos sin marcado CE<\/span><\/strong><\/li>\n<\/ul>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb width=\u00bb75.9%\u00bb custom_margin=\u00bb-23px|auto|-13px|159px|false|false\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_heading title=\u00bbCondiciones generales\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb title_font=\u00bb|||on|||||\u00bb title_text_color=\u00bb#0C71C3&#8243; min_height=\u00bb0px\u00bb custom_margin=\u00bb1px||||false|false\u00bb custom_padding=\u00bb7px|||||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover_enabled=\u00bbon|desktop\u00bb custom_padding__hover=\u00bb21px|||||\u00bb][\/et_pb_heading][et_pb_text _builder_version=\u00bb4.27.7&#8243; _module_preset=\u00bbdefault\u00bb custom_padding=\u00bb||0px|11px||\u00bb hover_enabled=\u00bb0&#8243; global_colors_info=\u00bb{}\u00bb sticky_enabled=\u00bb0&#8243;]<\/p>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"text-align: justify;\"><strong data-start=\"92\" data-end=\"117\"><strong data-start=\"92\" data-end=\"117\">Formato de solicitud: <\/strong><\/strong>En dos fases (pre-proposal y full proposal).<\/li>\n<li style=\"text-align: justify;\">\n<p data-start=\"92\" data-end=\"294\"><strong data-start=\"92\" data-end=\"117\">Pa\u00edses participantes: <\/strong><span>Austria, B\u00e9lgica, Rep\u00fablica Checa, Egipto, Francia, Alemania, Irlanda, Israel, Italia, Letonia, Lituania, Noruega, Polonia, Ruman\u00eda, Eslovaquia, Espa\u00f1a, Suecia, Turqu\u00eda y Reino Unido.<\/span><\/p>\n<\/li>\n<li style=\"text-align: justify;\">\n<p data-pm-slice=\"1 1 [&quot;list&quot;,{&quot;spread&quot;:true,&quot;start&quot;:11800,&quot;end&quot;:13681},&quot;regular_list_item&quot;,{&quot;start&quot;:12260,&quot;end&quot;:12484}]\" style=\"text-align: justify;\"><strong><span>Organizaci\u00f3n financiadora global:<\/span><\/strong><span> Breakthrough T1D (<\/span><strong><span>BT1D<\/span><\/strong><span>). En propuestas centradas en diabetes tipo 1, puede financiar socios de distintos pa\u00edses, incluidos pa\u00edses que no participen directamente en la convocatoria.<\/span><\/p>\n<\/li>\n<li style=\"text-align: justify;\">\n<p data-pm-slice=\"1 1 [&quot;list&quot;,{&quot;spread&quot;:true,&quot;start&quot;:11800,&quot;end&quot;:13681},&quot;regular_list_item&quot;,{&quot;start&quot;:12666,&quot;end&quot;:12698}]\"><strong><span>Duraci\u00f3n m\u00e1xima:<\/span><\/strong><span> 48 meses.<\/span><\/p>\n<\/li>\n<li>\n<p data-start=\"1418\" data-end=\"1521\" style=\"text-align: justify;\">Las entidades andaluzas podr\u00e1n solicitar fondos a uno de los siguientes organismos financiadores (cuant\u00edas por confirmar).<\/p>\n<ul data-start=\"1523\" data-end=\"1819\">\n<li data-start=\"1523\" data-end=\"1672\" style=\"text-align: justify;\">\n<p data-start=\"1525\" data-end=\"1595\">Spanish Health Ministry (Instituto de Salud Carlos III \u2013 ISCIII)<\/p>\n<\/li>\n<li data-start=\"1674\" data-end=\"1819\">\n<p data-start=\"1676\" data-end=\"1744\" style=\"text-align: justify;\">Consejer\u00eda de Presidencia, Sanidad y Emergencias de la Junta de Andaluc\u00eda.<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li style=\"text-align: justify;\"><strong>B\u00fasqueda de socios<\/strong>: Los investigadores interesados en participar en la convocatoria y que necesiten identificar potenciales socios para formar un consorcio podr\u00e1n utilizar la plataforma <strong><span>\u00a0<a href=\"https:\/\/partfinder.ncbr.gov.pl\/\">PartFinder<\/a>\u00a0<\/span><\/strong><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb width=\u00bb75.9%\u00bb min_height=\u00bb268px\u00bb custom_margin=\u00bb-14px|auto||159px|false|false\u00bb custom_padding=\u00bb0px||0px|||\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_heading title=\u00bbfechas clave\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb title_font=\u00bb|||on|||||\u00bb title_text_color=\u00bb#0C71C3&#8243; min_height=\u00bb0px\u00bb custom_margin=\u00bb1px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover_enabled=\u00bbon|desktop\u00bb][\/et_pb_heading][et_pb_text _builder_version=\u00bb4.27.7&#8243; _module_preset=\u00bbdefault\u00bb custom_padding=\u00bb||0px|11px||\u00bb hover_enabled=\u00bb0&#8243; global_colors_info=\u00bb{}\u00bb sticky_enabled=\u00bb0&#8243;]<\/p>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li><strong><span>27 de octubre de 2026:<\/span><\/strong><span> publicaci\u00f3n oficial de la convocatoria IICS4all 2027.<\/span><\/li>\n<li>\n<p><strong><span>10 de noviembre de 2026:<\/span><\/strong><span> sesi\u00f3n informativa online para solicitantes.<\/span><\/p>\n<\/li>\n<li>\n<p><strong><span>14 de enero de 2027, 12:00 CET:<\/span><\/strong><span> fecha l\u00edmite para la presentaci\u00f3n de pre-propuestas.<\/span><\/p>\n<\/li>\n<li>\n<p><strong><span>Mediados de abril de 2027:<\/span><\/strong><span> comunicaci\u00f3n de los resultados de la evaluaci\u00f3n de pre-propuestas e invitaci\u00f3n a presentar propuesta completa.<\/span><\/p>\n<\/li>\n<li>\n<p><strong><span>14 de junio de 2027, 12:00 CEST:<\/span><\/strong><span> fecha l\u00edmite para la presentaci\u00f3n de propuestas completas.<\/span><\/p>\n<\/li>\n<li>\n<p><strong><span>23 de agosto \u2013 3 de septiembre de 2027:<\/span><\/strong><span> fase de <\/span><em><span>rebuttal<\/span><\/em><span>.<\/span><\/p>\n<\/li>\n<li>\n<p><strong><span>Finales de octubre de 2027:<\/span><\/strong><span> comunicaci\u00f3n de las decisiones de financiaci\u00f3n.<\/span><\/p>\n<\/li>\n<li>\n<p><strong><span>Enero \u2013 mayo de 2028:<\/span><\/strong><span> inicio previsto de los proyectos, sujeto a los procedimientos nacionales.<\/span><\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb width=\u00bb75.9%\u00bb custom_margin=\u00bb20px|auto||159px|false|false\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_heading title=\u00bbDocumentaci\u00f3n y enlaces clave\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb title_font=\u00bb|||on|||||\u00bb title_text_color=\u00bb#0C71C3&#8243; min_height=\u00bb0px\u00bb custom_margin=\u00bb1px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover_enabled=\u00bbon|desktop\u00bb][\/et_pb_heading][et_pb_text _builder_version=\u00bb4.27.7&#8243; _module_preset=\u00bbdefault\u00bb custom_padding=\u00bb|||11px||\u00bb hover_enabled=\u00bb0&#8243; global_colors_info=\u00bb{}\u00bb sticky_enabled=\u00bb0&#8243;]<\/p>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li data-start=\"6416\" data-end=\"6460\"><a href=\"https:\/\/ibima.eu\/wp-content\/uploads\/2026\/09\/ERA4Health_JTC9-IICS4all_Pre-announcement.pdf\">Texto del preanuncio<\/a><\/li>\n<li data-start=\"6416\" data-end=\"6460\"><a data-start=\"6418\" data-end=\"6458\" class=\"decorated-link\" href=\"https:\/\/era4health.eu\/calls\/pre_iics4all2027.php\">Web Convocatoria<\/a><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00bb1&#8243; _builder_version=\u00bb4.20.4&#8243; _module_preset=\u00bbdefault\u00bb background_color=\u00bb#195e7f\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_row column_structure=\u00bb1_4,1_4,1_4,1_4&#8243; _builder_version=\u00bb4.20.4&#8243; _module_preset=\u00bbdefault\u00bb custom_padding=\u00bb50px||50px||true|false\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb1_4&#8243; _builder_version=\u00bb4.20.4&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_image src=\u00bbhttps:\/\/ibima.eu\/wp-content\/uploads\/2023\/04\/Logoblancofondoazul.jpg\u00bb title_text=\u00bbLogoblancofondoazul\u00bb force_fullwidth=\u00bbon\u00bb _builder_version=\u00bb4.20.4&#8243; _module_preset=\u00bbdefault\u00bb transform_scale_tablet=\u00bb202%|202%\u00bb transform_scale_phone=\u00bb202%|202%\u00bb transform_scale_last_edited=\u00bbon|tablet\u00bb transform_translate_tablet=\u00bb75px|25px\u00bb transform_translate_phone=\u00bb85px|-15px\u00bb transform_translate_last_edited=\u00bbon|phone\u00bb transform_translate_linked_tablet=\u00bboff\u00bb transform_rotate_tablet=\u00bb\u00bb transform_rotate_phone=\u00bb\u00bb transform_rotate_last_edited=\u00bbon|tablet\u00bb transform_skew_tablet=\u00bb\u00bb transform_skew_phone=\u00bb\u00bb transform_skew_last_edited=\u00bbon|tablet\u00bb transform_origin_tablet=\u00bb\u00bb transform_origin_phone=\u00bb\u00bb transform_origin_last_edited=\u00bbon|tablet\u00bb transform_styles_last_edited=\u00bbon|phone\u00bb min_height_tablet=\u00bb\u00bb min_height_phone=\u00bb\u00bb min_height_last_edited=\u00bbon|desktop\u00bb custom_margin_tablet=\u00bb||0px|-5px|false|false\u00bb custom_margin_phone=\u00bb||30px|-17px|false|false\u00bb custom_margin_last_edited=\u00bbon|tablet\u00bb custom_padding=\u00bb|200px|||false|false\u00bb custom_padding_tablet=\u00bb0px|200px|||false|false\u00bb custom_padding_phone=\u00bb|200px|||false|false\u00bb custom_padding_last_edited=\u00bbon|desktop\u00bb transform_styles_tablet=\u00bb\u00bb transform_styles_phone=\u00bb\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_image][et_pb_text _builder_version=\u00bb4.27.0&#8243; _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb14px|||-11%|false|false\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p class=\"x_MsoNormal\" style=\"text-align: left;\"><span style=\"color: #ffffff;\"><img decoding=\"async\" src=\"https:\/\/ibima.eu\/wp-content\/uploads\/2024\/03\/contact.png\" width=\"20\" style=\"position: relative; top: 3px; left: -5px; float: left;\" \/>Avenida Severo Ochoa, 35, 29590, M\u00e1laga<\/span><\/p>\n<p style=\"color: #ffffff;\"><img decoding=\"async\" src=\"https:\/\/ibima.eu\/wp-content\/uploads\/2024\/03\/phone.png\" width=\"20\" style=\"position: relative; top: 3px; left: -5px;\" \/>952 36 76 00<\/p>\n<p><a href=\"mailto:info@ibima.eu\" data-linkindex=\"0\" id=\"LPlnk315329\"><img decoding=\"async\" src=\"https:\/\/ibima.eu\/wp-content\/uploads\/2024\/03\/email.png\" width=\"20\" style=\"position: relative; top: 3px; left: -5px;\" \/>info@ibima.eu<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=\u00bb1_4&#8243; _builder_version=\u00bb4.20.4&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][dsm_menu title=\u00bbAPARTADOS PRINCIPALES\u00bb menu_id=\u00bb1332&#8243; menu_link_text_color=\u00bb#FFFFFF\u00bb active_link_color=\u00bb#FFFFFF\u00bb menu_link_text_active_color=\u00bb#FFFFFF\u00bb menu_link_text_visited_color=\u00bb#FFFFFF\u00bb list_style_type=\u00bbnone\u00bb _builder_version=\u00bb4.24.0&#8243; _module_preset=\u00bbdefault\u00bb header_font=\u00bbPoppins||||||||\u00bb header_text_align=\u00bbleft\u00bb header_text_color=\u00bb#FFFFFF\u00bb header_font_size=\u00bb20px\u00bb custom_margin_tablet=\u00bb200px||||false|false\u00bb custom_margin_phone=\u00bb0px||||false|false\u00bb custom_margin_last_edited=\u00bbon|tablet\u00bb global_colors_info=\u00bb{}\u00bb][\/dsm_menu][\/et_pb_column][et_pb_column type=\u00bb1_4&#8243; _builder_version=\u00bb4.20.4&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][dsm_menu title=\u00bbTEXTOS LEGALES\u00bb menu_id=\u00bb1333&#8243; menu_link_text_color=\u00bb#FFFFFF\u00bb active_link_color=\u00bb#FFFFFF\u00bb menu_link_text_active_color=\u00bb#FFFFFF\u00bb menu_link_text_visited_color=\u00bb#FFFFFF\u00bb list_style_type=\u00bbnone\u00bb _builder_version=\u00bb4.20.4&#8243; _module_preset=\u00bbdefault\u00bb header_font=\u00bbPoppins||||||||\u00bb header_text_align=\u00bbleft\u00bb header_text_color=\u00bb#FFFFFF\u00bb header_font_size=\u00bb20px\u00bb custom_margin_tablet=\u00bb-155px||||false|false\u00bb custom_margin_phone=\u00bb0px||||false|false\u00bb custom_margin_last_edited=\u00bbon|tablet\u00bb global_colors_info=\u00bb{}\u00bb][\/dsm_menu][\/et_pb_column][et_pb_column type=\u00bb1_4&#8243; _builder_version=\u00bb4.20.4&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_social_media_follow _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb custom_margin_tablet=\u00bb5px||||false|false\u00bb custom_margin_phone=\u00bb5px||||false|false\u00bb custom_margin_last_edited=\u00bbon|tablet\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_social_media_follow_network social_network=\u00bbtwitter\u00bb url=\u00bbhttps:\/\/x.com\/_ibima?lang=es%20&#8243; _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb background_color=\u00bb#000000&#8243; global_colors_info=\u00bb{}\u00bb follow_button=\u00bboff\u00bb url_new_window=\u00bbon\u00bb]twitter[\/et_pb_social_media_follow_network][et_pb_social_media_follow_network social_network=\u00bbfacebook\u00bb url=\u00bbhttps:\/\/www.facebook.com\/Ibima.eu\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb background_color=\u00bb#3b5998&#8243; global_colors_info=\u00bb{}\u00bb follow_button=\u00bboff\u00bb url_new_window=\u00bbon\u00bb]facebook[\/et_pb_social_media_follow_network][et_pb_social_media_follow_network social_network=\u00bbinstagram\u00bb url=\u00bbhttps:\/\/www.instagram.com\/ibima_mlg\/\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb background_color=\u00bb#ea2c59&#8243; global_colors_info=\u00bb{}\u00bb follow_button=\u00bboff\u00bb url_new_window=\u00bbon\u00bb]instagram[\/et_pb_social_media_follow_network][et_pb_social_media_follow_network social_network=\u00bblinkedin\u00bb url=\u00bbhttps:\/\/es.linkedin.com\/company\/ibima\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb background_color=\u00bb#007bb6&#8243; global_colors_info=\u00bb{}\u00bb follow_button=\u00bboff\u00bb url_new_window=\u00bbon\u00bb]linkedin[\/et_pb_social_media_follow_network][et_pb_social_media_follow_network social_network=\u00bbyoutube\u00bb url=\u00bbhttps:\/\/www.youtube.com\/channel\/UCY3UUZTi9X0ur-1Gd6MKonw\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb background_color=\u00bb#a82400&#8243; global_colors_info=\u00bb{}\u00bb follow_button=\u00bboff\u00bb url_new_window=\u00bbon\u00bb]youtube[\/et_pb_social_media_follow_network][\/et_pb_social_media_follow][dsm_icon_list _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb text_font=\u00bbPoppins|600|||||||\u00bb custom_margin=\u00bb20px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb][dsm_icon_list_child text=\u00bbBuz\u00f3n de sugerencias\u00bb font_icon=\u00bb&#x3d;||divi||400&#8243; icon_color=\u00bb#FFFFFF\u00bb url=\u00bbhttps:\/\/ibima.eu\/es\/comunicacion-con-el-instituto\/\u00bb url_new_window=\u00bbon\u00bb _builder_version=\u00bb4.24.2&#8243; _module_preset=\u00bbdefault\u00bb text_text_color=\u00bb#FFFFFF\u00bb global_colors_info=\u00bb{}\u00bb][\/dsm_icon_list_child][dsm_icon_list_child text=\u00bbBuz\u00f3n de denuncias\u00bb font_icon=\u00bb&#x3d;||divi||400&#8243; icon_color=\u00bb#FFFFFF\u00bb url=\u00bbhttps:\/\/ibima.eu\/es\/canal-de-denuncias\/\u00bb url_new_window=\u00bbon\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb text_text_color=\u00bb#FFFFFF\u00bb global_colors_info=\u00bb{}\u00bb][\/dsm_icon_list_child][\/dsm_icon_list][dsm_icon_list _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb text_font=\u00bbPoppins|600|||||||\u00bb custom_margin=\u00bb20px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb][dsm_icon_list_child text=\u00bbSuscr\u00edbete al Canal de Divulgaci\u00f3n\u00bb font_icon=\u00bb&#x3d;||divi||400&#8243; icon_color=\u00bb#FFFFFF\u00bb url=\u00bbhttps:\/\/forms.gle\/5mczd4KKMqkBPdBy7&#8243; url_new_window=\u00bbon\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb text_text_color=\u00bb#FFFFFF\u00bb global_colors_info=\u00bb{}\u00bb][\/dsm_icon_list_child][\/dsm_icon_list][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00bb1&#8243; custom_padding_last_edited=\u00bbon|tablet\u00bb _builder_version=\u00bb4.27.5&#8243; _module_preset=\u00bbdefault\u00bb background_color=\u00bb#195e7f\u00bb custom_padding_tablet=\u00bb25px||||false|false\u00bb custom_padding_phone=\u00bb25px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_row column_structure=\u00bb1_4,1_4,1_4,1_4&#8243; _builder_version=\u00bb4.27.5&#8243; _module_preset=\u00bbdefault\u00bb background_color=\u00bb#195e7f\u00bb custom_padding=\u00bb50px||50px||true|false\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb1_4&#8243; _builder_version=\u00bb4.20.4&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_image src=\u00bbhttps:\/\/ibima.eu\/wp-content\/uploads\/2023\/04\/Logoblancofondoazul.jpg\u00bb title_text=\u00bbLogoblancofondoazul\u00bb force_fullwidth=\u00bbon\u00bb _builder_version=\u00bb4.20.4&#8243; _module_preset=\u00bbdefault\u00bb transform_scale_tablet=\u00bb202%|202%\u00bb transform_scale_phone=\u00bb202%|202%\u00bb transform_scale_last_edited=\u00bbon|tablet\u00bb transform_translate_tablet=\u00bb75px|25px\u00bb transform_translate_phone=\u00bb85px|-15px\u00bb transform_translate_last_edited=\u00bbon|phone\u00bb transform_translate_linked_tablet=\u00bboff\u00bb transform_rotate_tablet=\u00bb\u00bb transform_rotate_phone=\u00bb\u00bb transform_rotate_last_edited=\u00bbon|tablet\u00bb transform_skew_tablet=\u00bb\u00bb transform_skew_phone=\u00bb\u00bb transform_skew_last_edited=\u00bbon|tablet\u00bb transform_origin_tablet=\u00bb\u00bb transform_origin_phone=\u00bb\u00bb transform_origin_last_edited=\u00bbon|tablet\u00bb transform_styles_last_edited=\u00bbon|phone\u00bb min_height_tablet=\u00bb\u00bb min_height_phone=\u00bb\u00bb min_height_last_edited=\u00bbon|desktop\u00bb custom_margin_tablet=\u00bb||0px|-5px|false|false\u00bb custom_margin_phone=\u00bb||30px|-17px|false|false\u00bb custom_margin_last_edited=\u00bbon|tablet\u00bb custom_padding=\u00bb|200px|||false|false\u00bb custom_padding_tablet=\u00bb0px|200px|||false|false\u00bb custom_padding_phone=\u00bb|200px|||false|false\u00bb custom_padding_last_edited=\u00bbon|desktop\u00bb transform_styles_tablet=\u00bb\u00bb transform_styles_phone=\u00bb\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_image][et_pb_text _builder_version=\u00bb4.27.5&#8243; _module_preset=\u00bbdefault\u00bb text_text_color=\u00bb#FFFFFF\u00bb custom_margin=\u00bb14px|||-11%|false|false\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p class=\"x_MsoNormal\" style=\"text-align: left;\"><span style=\"color: #ffffff;\"><img decoding=\"async\" src=\"https:\/\/ibima.eu\/wp-content\/uploads\/2024\/03\/contact.png\" width=\"20\" style=\"position: relative; top: 3px; left: -5px; float: left;\" \/>Avenida Severo Ochoa, 35, 29590, M\u00e1laga<\/span><\/p>\n<p style=\"color: #ffffff;\"><img decoding=\"async\" src=\"https:\/\/ibima.eu\/wp-content\/uploads\/2024\/03\/phone.png\" width=\"20\" style=\"position: relative; top: 3px; left: -5px;\" \/>952 36 76 00<\/p>\n<p><a href=\"mailto:info@ibima.eu\" data-linkindex=\"0\" id=\"LPlnk315329\"><img decoding=\"async\" src=\"https:\/\/ibima.eu\/wp-content\/uploads\/2024\/03\/email.png\" width=\"20\" style=\"position: relative; top: 3px; left: -5px;\" \/>info@ibima.eu<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=\u00bb1_4&#8243; _builder_version=\u00bb4.20.4&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][dsm_menu title=\u00bbAPARTADOS PRINCIPALES\u00bb menu_id=\u00bb1332&#8243; menu_link_text_color=\u00bb#FFFFFF\u00bb active_link_color=\u00bb#FFFFFF\u00bb menu_link_text_active_color=\u00bb#FFFFFF\u00bb menu_link_text_visited_color=\u00bb#FFFFFF\u00bb list_style_type=\u00bbnone\u00bb _builder_version=\u00bb4.27.7&#8243; _module_preset=\u00bbdefault\u00bb header_font=\u00bbPoppins||||||||\u00bb header_text_align=\u00bbleft\u00bb header_text_color=\u00bb#FFFFFF\u00bb header_font_size=\u00bb20px\u00bb custom_margin_tablet=\u00bb200px||||false|false\u00bb custom_margin_phone=\u00bb0px||||false|false\u00bb custom_margin_last_edited=\u00bbon|tablet\u00bb global_colors_info=\u00bb{}\u00bb][\/dsm_menu][\/et_pb_column][et_pb_column type=\u00bb1_4&#8243; _builder_version=\u00bb4.20.4&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][dsm_menu title=\u00bbTEXTOS LEGALES\u00bb menu_id=\u00bb1333&#8243; menu_link_text_color=\u00bb#FFFFFF\u00bb active_link_color=\u00bb#FFFFFF\u00bb menu_link_text_active_color=\u00bb#FFFFFF\u00bb menu_link_text_visited_color=\u00bb#FFFFFF\u00bb list_style_type=\u00bbnone\u00bb _builder_version=\u00bb4.20.4&#8243; _module_preset=\u00bbdefault\u00bb header_font=\u00bbPoppins||||||||\u00bb header_text_align=\u00bbleft\u00bb header_text_color=\u00bb#FFFFFF\u00bb header_font_size=\u00bb20px\u00bb custom_margin_tablet=\u00bb-155px||||false|false\u00bb custom_margin_phone=\u00bb0px||||false|false\u00bb custom_margin_last_edited=\u00bbon|tablet\u00bb global_colors_info=\u00bb{}\u00bb][\/dsm_menu][\/et_pb_column][et_pb_column type=\u00bb1_4&#8243; _builder_version=\u00bb4.20.4&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_social_media_follow _builder_version=\u00bb4.27.7&#8243; _module_preset=\u00bbdefault\u00bb custom_margin_tablet=\u00bb5px||||false|false\u00bb custom_margin_phone=\u00bb5px||||false|false\u00bb custom_margin_last_edited=\u00bbon|tablet\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_social_media_follow_network social_network=\u00bbtwitter\u00bb url=\u00bbhttps:\/\/x.com\/_ibima?lang=es%20&#8243; _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb background_color=\u00bb#000000&#8243; global_colors_info=\u00bb{}\u00bb follow_button=\u00bboff\u00bb url_new_window=\u00bbon\u00bb]twitter[\/et_pb_social_media_follow_network][et_pb_social_media_follow_network social_network=\u00bbfacebook\u00bb url=\u00bbhttps:\/\/www.facebook.com\/Ibima.eu\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb background_color=\u00bb#3b5998&#8243; global_colors_info=\u00bb{}\u00bb follow_button=\u00bboff\u00bb url_new_window=\u00bbon\u00bb]facebook[\/et_pb_social_media_follow_network][et_pb_social_media_follow_network social_network=\u00bbinstagram\u00bb url=\u00bbhttps:\/\/www.instagram.com\/_ibima\/\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb background_color=\u00bb#ea2c59&#8243; global_colors_info=\u00bb{}\u00bb follow_button=\u00bboff\u00bb url_new_window=\u00bbon\u00bb]instagram[\/et_pb_social_media_follow_network][et_pb_social_media_follow_network social_network=\u00bblinkedin\u00bb url=\u00bbhttps:\/\/es.linkedin.com\/company\/ibima\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb background_color=\u00bb#007bb6&#8243; global_colors_info=\u00bb{}\u00bb follow_button=\u00bboff\u00bb url_new_window=\u00bbon\u00bb]linkedin[\/et_pb_social_media_follow_network][et_pb_social_media_follow_network social_network=\u00bbyoutube\u00bb url=\u00bbhttps:\/\/www.youtube.com\/channel\/UCY3UUZTi9X0ur-1Gd6MKonw\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb background_color=\u00bb#a82400&#8243; global_colors_info=\u00bb{}\u00bb follow_button=\u00bboff\u00bb url_new_window=\u00bbon\u00bb]youtube[\/et_pb_social_media_follow_network][et_pb_social_media_follow_network social_network=\u00bbtiktok\u00bb url=\u00bbhttps:\/\/www.tiktok.com\/@_ibima\u00bb _builder_version=\u00bb4.27.7&#8243; _module_preset=\u00bbdefault\u00bb background_color=\u00bb#fe2c55&#8243; global_colors_info=\u00bb{}\u00bb follow_button=\u00bboff\u00bb url_new_window=\u00bbon\u00bb]tiktok[\/et_pb_social_media_follow_network][\/et_pb_social_media_follow][dsm_icon_list _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb text_font=\u00bbPoppins|600|||||||\u00bb custom_margin=\u00bb20px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb][dsm_icon_list_child text=\u00bbBuz\u00f3n de sugerencias\u00bb font_icon=\u00bb&#x3d;||divi||400&#8243; icon_color=\u00bb#FFFFFF\u00bb url=\u00bbhttps:\/\/ibima.eu\/es\/comunicacion-con-el-instituto\/\u00bb url_new_window=\u00bbon\u00bb _builder_version=\u00bb4.24.2&#8243; _module_preset=\u00bbdefault\u00bb text_text_color=\u00bb#FFFFFF\u00bb global_colors_info=\u00bb{}\u00bb][\/dsm_icon_list_child][dsm_icon_list_child text=\u00bbBuz\u00f3n de denuncias\u00bb font_icon=\u00bb&#x3d;||divi||400&#8243; icon_color=\u00bb#FFFFFF\u00bb url=\u00bbhttps:\/\/ibima.eu\/es\/canal-de-denuncias\/\u00bb url_new_window=\u00bbon\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb text_text_color=\u00bb#FFFFFF\u00bb global_colors_info=\u00bb{}\u00bb][\/dsm_icon_list_child][\/dsm_icon_list][dsm_icon_list _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb text_font=\u00bbPoppins|600|||||||\u00bb custom_margin=\u00bb20px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb][dsm_icon_list_child text=\u00bbSuscr\u00edbete al Canal de Divulgaci\u00f3n\u00bb font_icon=\u00bb&#x3d;||divi||400&#8243; icon_color=\u00bb#FFFFFF\u00bb url=\u00bbhttps:\/\/forms.gle\/5mczd4KKMqkBPdBy7&#8243; url_new_window=\u00bbon\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb text_text_color=\u00bb#FFFFFF\u00bb global_colors_info=\u00bb{}\u00bb][\/dsm_icon_list_child][\/dsm_icon_list][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>La Asociaci\u00f3n Europea ERA4Health ha preanunciado la convocatoria IICS4all 2027 \u2013 Multi-national Investigator-Initiated Clinical Studies in Cardiovascular, Autoimmune, Metabolic, and Non-Communicable Respiratory Diseases, including Underrepresented Populations, dedicada a financiar ensayos cl\u00ednicos multic\u00e9ntricos e iniciados por investigadores en enfermedades cardiovasculares, trastornos metab\u00f3licos, enfermedades autoinmunes y enfermedades respiratorias no transmisibles.El objetivo de IICS4all 2027 es apoyar estudios [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"class_list":["post-58023","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>era4health-iics4all-2027 - Ibima<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ibima.eu\/es\/era4health-iics4all-2027\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"era4health-iics4all-2027 - Ibima\" \/>\n<meta property=\"og:description\" content=\"La Asociaci\u00f3n Europea ERA4Health ha preanunciado la convocatoria IICS4all 2027 \u2013 Multi-national Investigator-Initiated Clinical Studies in Cardiovascular, Autoimmune, Metabolic, and Non-Communicable Respiratory Diseases, including Underrepresented Populations, dedicada a financiar ensayos cl\u00ednicos multic\u00e9ntricos e iniciados por investigadores en enfermedades cardiovasculares, trastornos metab\u00f3licos, enfermedades autoinmunes y enfermedades respiratorias no transmisibles.El objetivo de IICS4all 2027 es apoyar estudios [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ibima.eu\/es\/era4health-iics4all-2027\/\" \/>\n<meta property=\"og:site_name\" content=\"Ibima\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-29T08:36:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ibima.eu\/wp-content\/uploads\/2024\/03\/contact.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"5 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/era4health-iics4all-2027\\\/\",\"url\":\"https:\\\/\\\/ibima.eu\\\/era4health-iics4all-2027\\\/\",\"name\":\"era4health-iics4all-2027 - Ibima\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/era4health-iics4all-2027\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/era4health-iics4all-2027\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ibima.eu\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/contact.png\",\"datePublished\":\"2025-10-15T10:57:09+00:00\",\"dateModified\":\"2026-09-29T08:36:11+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/era4health-iics4all-2027\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ibima.eu\\\/era4health-iics4all-2027\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/era4health-iics4all-2027\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ibima.eu\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/contact.png\",\"contentUrl\":\"https:\\\/\\\/ibima.eu\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/contact.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/era4health-iics4all-2027\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/ibima.eu\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"era4health-iics4all-2027\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/ibima.eu\\\/es\\\/\",\"name\":\"Ibima\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ibima.eu\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"era4health-iics4all-2027 - Ibima","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ibima.eu\/es\/era4health-iics4all-2027\/","og_locale":"es_ES","og_type":"article","og_title":"era4health-iics4all-2027 - Ibima","og_description":"La Asociaci\u00f3n Europea ERA4Health ha preanunciado la convocatoria IICS4all 2027 \u2013 Multi-national Investigator-Initiated Clinical Studies in Cardiovascular, Autoimmune, Metabolic, and Non-Communicable Respiratory Diseases, including Underrepresented Populations, dedicada a financiar ensayos cl\u00ednicos multic\u00e9ntricos e iniciados por investigadores en enfermedades cardiovasculares, trastornos metab\u00f3licos, enfermedades autoinmunes y enfermedades respiratorias no transmisibles.El objetivo de IICS4all 2027 es apoyar estudios [&hellip;]","og_url":"https:\/\/ibima.eu\/es\/era4health-iics4all-2027\/","og_site_name":"Ibima","article_modified_time":"2026-09-29T08:36:11+00:00","og_image":[{"url":"https:\/\/ibima.eu\/wp-content\/uploads\/2024\/03\/contact.png","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"5 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ibima.eu\/era4health-iics4all-2027\/","url":"https:\/\/ibima.eu\/era4health-iics4all-2027\/","name":"era4health-iics4all-2027 - Ibima","isPartOf":{"@id":"https:\/\/ibima.eu\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ibima.eu\/era4health-iics4all-2027\/#primaryimage"},"image":{"@id":"https:\/\/ibima.eu\/era4health-iics4all-2027\/#primaryimage"},"thumbnailUrl":"https:\/\/ibima.eu\/wp-content\/uploads\/2024\/03\/contact.png","datePublished":"2025-10-15T10:57:09+00:00","dateModified":"2026-09-29T08:36:11+00:00","breadcrumb":{"@id":"https:\/\/ibima.eu\/era4health-iics4all-2027\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ibima.eu\/era4health-iics4all-2027\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ibima.eu\/era4health-iics4all-2027\/#primaryimage","url":"https:\/\/ibima.eu\/wp-content\/uploads\/2024\/03\/contact.png","contentUrl":"https:\/\/ibima.eu\/wp-content\/uploads\/2024\/03\/contact.png"},{"@type":"BreadcrumbList","@id":"https:\/\/ibima.eu\/era4health-iics4all-2027\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/ibima.eu\/es\/"},{"@type":"ListItem","position":2,"name":"era4health-iics4all-2027"}]},{"@type":"WebSite","@id":"https:\/\/ibima.eu\/es\/#website","url":"https:\/\/ibima.eu\/es\/","name":"Ibima","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ibima.eu\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"}]}},"_links":{"self":[{"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/pages\/58023","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/comments?post=58023"}],"version-history":[{"count":23,"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/pages\/58023\/revisions"}],"predecessor-version":[{"id":63236,"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/pages\/58023\/revisions\/63236"}],"wp:attachment":[{"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/media?parent=58023"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}